Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images

A blockbuster IPO from an under-the-radar health care company is reviving hopes for a strong year of stock offerings. Medline, a medical supplier, raised nearly $6.3 billion earlier this week in the largest IPO this year and the largest since Rivian’s public debut in 2021. The company’s stock jumped 41 percent after opening at $35 on Nasdaq on Wednesday (Dec. 17). “The huge demand for Medline’s IPO in the last week is a strong market to end the year with,” Sam Kerr, head of global ECM at Mergermarket, told Observer in a statement.

Sign Up For Our Daily Newsletter

Thank you for signing up!

By clicking submit, you agree to our terms of service and........

© Observer